Breakthrough in Vaccine 2020 Conference Event Name: 3rd International Conference Vaccines & Vaccination (Vaccine 2020)| May 20-21, 2020 Theme: Advances in Immunology & Vaccine Technology and Their Impact Aim and Scope: Vaccine is a biological preparation that provides active acquired immunity to a particular disease. Immunization currently prevents an estimated 2 to 3 million deaths [….]
Coronavirus/COVID-19 Vaccine Insights from Altimmune’s Leadership Team Coronavirus/COVID-19 continues to radically change daily life across the U.S. Governor Larry Hogan issued an executive order on March 15th ordering the closure of restaurants (take out only), bars, theaters, and fitness centers until further notice from the state. The CDC also changed its guidelines for gatherings from [….]
Altimmune Becomes The Second Maryland-Based Biotech Advance Potential Coronavirus/COVID-19 Vaccine As the coronavirus COVID-19 continues to spread across the U.S. — there are currently 150 confirmed cases with 11 total deaths as of this writing — several BioHealth Capital Region (BHCR) life science companies are urgently pushing to develop and deploy a COVID-19 vaccine. In [….]
What’s Behind Novavax’s Coronavirus/COVID-19 Vaccine Development Program The BioHealth Capital Region (BHCR) has a long history of leading the fight against new, frightening diseases, like Ebola and the novel Coronavirus (COVID-19) which is quickly spreading across the globe. Leading public health agencies such as the World Health Organization (WHO) and others believe the COVID-19 virus [….]
U.S. Coronavirus Response Could Include These BioHealth Capital Region Organizations The streets of Wuhan, China — the epicenter of the coronavirus outbreak — are empty and quiet except for the sound of loudspeakers squawking quarantine instructions to its sheltered-in-place residents. Flights to some Chinese cities have been terminated. A Tokyo, Japan-based travel agency has canceled [….]
Antimicrobial resistance (AMR) is in the news lately and for good reason. Diseases that were once easy to treat are becoming increasingly difficult to cure. But the largest contributor to AMR is a disease that rarely makes headlines – drug-resistant tuberculosis (DR-TB), the world’s only airborne drug-resistant infection. DR-TB makes up a third of the [….]
Leidos’s New Virtual Biotech Startup ‘ExGloH’ Targets Cancer and Infectious Diseases with Improved T Cell Therapies Leidos’s ExGloH Leverages Entrepreneurial Science and Industry-Leading Support Infrastructure to Improve Global Health June 4, 2019 The seed for Leidos’s newest division—and virtual startup biotech—Explorations in Global Health (ExGloH) was planted nearly 20 years ago. In 2000, Leidos secured [….]
4 Vaccine and Immunotherapy Companies in Maryland That Are Redefining the Capabilities of Modern Medicine Maryland’s World Leading Vaccine Hub Showcased at Fourth Annual MTC Life Science Breakfast January 22, 2019 It might be cold and snowy across the DMV, but one thing is for sure—vaccine and immunotherapy companies are hot in the BioHealth Capital [….]
$2.5 Million Grant Awarded to BioHealth Capital Region Research Collaborative to Fight Deadly Virus Scientists from across the BioHealth Capital Region will collaborate on a five-year, $2.5 million grant from the Department of Defense to fight the Venezuelan equine encephalitis virus (VEEV), a South American-borne disease that can cause long-term neurological problems and even death. [….]
Path to World Vaccine Conference was through ‘Vaccine Alley’ this year More than a dozen biotech companies or researchers from the Maryland biotech cluster, which some have also dubbed ‘Vaccine Alley’, were among the most recognized finalists at this year’s Vaccine Industry Excellence (ViE) Awards in Washington, DC at the World Vaccine Conference. In fact, [….]
